Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TIROFIBAN vs TISAGENLECLEUCEL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TIROFIBAN vs TISAGENLECLEUCEL: Safety Overview

Metric TIROFIBAN TISAGENLECLEUCEL
Total FAERS Reports 2,166 4,229
Deaths Reported 232 1,232
Death Rate 10.7% 29.1%
Hospitalizations 185 1,256
Average Patient Age 61.8 yrs 39.1 yrs
% Female Patients 48.1% 38.4%
FDA Approval Date Apr 20, 2000 N/A
Manufacturer Medicure International Inc Novartis Pharmaceuticals Corporation
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued N/A